- Scrip Originals
Brought to you by
Novartis licenses cholesterol fighting compound from Bruin
20 Sep 2005
Novartis AG has licensed the rights to a Phase I oral cholesterol medication from start-up biotech company Bruin Pharmaceuticals.
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com